Psychedelics such as psilocybin and MDMA may be a promising treatment avenue for Prolonged Grief Disorder (PGD).
Randomized clinical trials demonstrated the efficacy of psilocybin in reducing symptom severity in depression and MDMA in reducing PTSD symptomatology.
Furthermore, psychedelics often produce subjective effects (such as transcendence, mystical experiences, and a sense of oneness) that may be uniquely relevant to the existential distress experienced in PGD.
Read more
Psychedelic nonprofit Unlimited Sciences announced the Psychedelic Info Line providing callers with fact-based information on psychedelics.
People are encouraged to call toll-free 1 (888) 210-3553 (Monday through Thursday from 8:00 a.m. – 5:00 p.m. MST or email.
Read more
Keep reading for an interview with pioneering psychedelic activist Rick Doblin about the promise of MDMA therapy for PTSD, working with Republicans, and his hope for a drug-assisted global spiritual awakening.
Read more
Could psychedelics ease mental health toll from COVID-19, and other crises?
Read more
The film DOSED shows that psychedelic therapies can be immensely beneficial, but are often not one-shot wonders or magic pills. Here’s an interview on the making of the film.
Read more
Author Paul Levy further explores shamanism, alchemy and healing. Take your time with this one, he shares incredible information here.
Read more
Traumatic events such as pandemics can spur transformative psychological growth.
Read more
Non-ordinary states of consciousness hold psychological and spiritual contents that, when properly integrated, can offer tremendous life-affirming value. Keep reading for more!
Read more
Quisque iaculis facilisis lacinia. Mauris euismod pellentesque tellus sit amet mollis.